Yamily Moreno
Psychiatric/Mental Health · Corpus Christi, TXNPI 1134698780
Payments from drug & device makers
Across 156 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$408
- Takeda Pharmaceuticals U.S.A., Inc.$230
- Johnson & Johnson$226
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$214
- Teva Pharmaceuticals USA, Inc.$208
- Alkermes, Inc.$206
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,73998%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 27 | $408 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $230 |
| Johnson & Johnson | 10 | $226 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $214 |
| Teva Pharmaceuticals USA, Inc. | 10 | $208 |
| Alkermes, Inc. | 11 | $206 |
| AbbVie | 15 | $204 |
| Lundbeck LLC | 9 | $172 |
| Otsuka America Pharmaceutical, Inc. | 8 | $160 |
| Tris Pharma Inc | 8 | $136 |
| Idorsia Pharmaceuticals US Inc | 7 | $129 |
| Merck | 6 | $93 |
| Eisai Inc. | 5 | $88 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Corium, LLC | 4 | $77 |
| Bausch Health US, LLC | 3 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Neuronetics, Inc. | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
How this compares
$2,786 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 12 | $5,541 |
| Bupropion XlBupropion Hcl | 38 | $535 |
| Divalproex Sodium | 11 | $201 |
| Alprazolam | 52 | $156 |
| Paroxetine Hcl | 18 | $129 |
| Clonazepam | 19 | $39 |
| Trazodone Hcl | 13 | $38 |
| Zolpidem Tartrate | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $230 | $5,54112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Corpus Christi
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.